| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Legorreta Pablo G. | 20% | $3,372,819,557 | 103,112,796 | Legorreta G. Pablo | 16 May 2025 | |||
| MORGAN STANLEY | 9.2% | $1,394,427,274 | 38,907,011 | Morgan Stanley | 30 Jun 2025 | |||
| Severgnini Achille G. | 6.9% | -18% | $978,885,021 | -$198,725,189 | 29,926,170 | -17% | Severgnini Achille G. | 30 Apr 2025 |
| Capital International Investors | 6.6% | +18% | $1,005,907,876 | +$190,516,586 | 28,512,128 | +23% | Capital International Investors | 30 Sep 2025 |
| FMR LLC | 6.5% | -29% | $984,337,180 | -$400,247,331 | 27,900,714 | -29% | FMR LLC | 30 Sep 2025 |
| BlackRock, Inc. | 5.7% | $832,319,492 | 25,445,414 | BlackRock, Inc. | 31 Dec 2024 | |||
| GENERAL ATLANTIC, L.P. | 3.2% | $510,500,301 | 14,243,870 | General Atlantic, L.P. | 30 Jun 2025 | |||
| VANGUARD GROUP INC | 2.5% | $385,841,061 | 10,936,538 | The Vanguard Group | 30 Sep 2025 |
As of 30 Sep 2025, 481 institutional investors reported holding 327,868,362 shares of Royalty Pharma plc - Common Stock (RPRX). This represents 76% of the company’s total 432,001,939 outstanding shares.
The largest institutional shareholders of Royalty Pharma plc - Common Stock (RPRX) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 10% | 44,163,954 | -5.2% | 0.09% | $1,558,104,371 |
| FMR LLC | 6.5% | 27,986,714 | -31% | 0.05% | $987,371,261 |
| Capital International Investors | 6.3% | 27,212,694 | +24% | 0.15% | $960,063,844 |
| BlackRock, Inc. | 6.1% | 26,200,503 | +3% | 0.02% | $924,353,737 |
| BAILLIE GIFFORD & CO | 4% | 17,372,502 | -3.6% | 0.45% | $612,901,870 |
| Swedbank AB | 2.8% | 12,200,270 | +0.35% | 0.44% | $430,425,526 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.8% | 11,965,633 | +99% | 0.67% | $422,147,532 |
| VANGUARD GROUP INC | 2.5% | 10,936,538 | -70% | 0.01% | $385,841,060 |
| STATE STREET CORP | 2.4% | 10,272,753 | +0.76% | 0.01% | $362,422,726 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 7,617,413 | -6.8% | 0.02% | $268,026,898 |
| Caledonia (Private) Investments Pty Ltd | 1.7% | 7,547,609 | +17% | 4.3% | $266,279,646 |
| VICTORY CAPITAL MANAGEMENT INC | 1.1% | 4,657,407 | +3.7% | 0.1% | $164,313,319 |
| NORTHERN TRUST CORP | 0.94% | 4,075,239 | +1.3% | 0.02% | $143,774,431 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.76% | 3,282,174 | +10% | 0.07% | $115,795,099 |
| JANE STREET GROUP, LLC | 0.73% | 3,151,660 | +315% | 0.13% | $111,190,565 |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 0.72% | 3,129,936 | -23% | 0.02% | $110,424,143 |
| Patient Capital Management, LLC | 0.72% | 3,117,850 | +4.3% | 4.4% | $109,997,741 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.7% | 3,025,712 | +0.56% | 0.02% | $106,747,119 |
| NEW SOUTH CAPITAL MANAGEMENT INC | 0.68% | 2,918,263 | +1.1% | 4.7% | $102,956,319 |
| Legal & General Group Plc | 0.65% | 2,822,566 | +3.8% | 0.02% | $99,580,130 |
| BANK OF AMERICA CORP /DE/ | 0.61% | 2,646,772 | +30% | 0.01% | $93,378,104 |
| Qube Research & Technologies Ltd | 0.57% | 2,481,771 | +737% | 0.12% | $87,556,881 |
| Dorsey Asset Management, LLC | 0.54% | 2,350,449 | 7.5% | $82,923,841 | |
| MILLENNIUM MANAGEMENT LLC | 0.52% | 2,235,133 | +379% | 0.06% | $78,855,492 |
| DIMENSIONAL FUND ADVISORS LP | 0.49% | 2,100,490 | +11% | 0.02% | $74,104,248 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 4,758,756 | $184,412,338 | +$27,980,139 | $38.64 | 44 |
| 2025 Q3 | 327,868,362 | $11,565,824,183 | -$512,798,569 | $35.28 | 481 |
| 2025 Q2 | 342,210,637 | $12,333,363,729 | +$949,776,240 | $36.03 | 452 |
| 2025 Q1 | 317,255,108 | $9,879,343,045 | -$34,196,805 | $31.13 | 444 |
| 2024 Q4 | 320,707,173 | $8,183,523,072 | +$144,649,409 | $25.51 | 414 |
| 2024 Q3 | 312,434,792 | $8,832,030,084 | -$70,655,781 | $28.29 | 391 |
| 2024 Q2 | 316,171,106 | $8,334,967,211 | +$126,311,822 | $26.37 | 373 |
| 2024 Q1 | 311,994,207 | $9,469,625,864 | +$68,283,642 | $30.37 | 375 |
| 2023 Q4 | 310,848,061 | $8,731,929,890 | +$90,598,401 | $28.09 | 359 |
| 2023 Q3 | 300,556,312 | $8,159,558,450 | -$95,718,367 | $27.14 | 312 |
| 2023 Q2 | 302,776,880 | $9,312,865,143 | +$35,406,560 | $30.74 | 321 |
| 2023 Q1 | 301,740,017 | $10,870,806,631 | +$87,185,612 | $36.03 | 331 |
| 2022 Q4 | 299,214,570 | $11,818,548,636 | +$83,591,490 | $39.52 | 332 |
| 2022 Q3 | 298,186,963 | $11,983,269,244 | +$263,400,168 | $40.18 | 311 |
| 2022 Q2 | 291,545,338 | $12,256,604,812 | +$918,924,477 | $42.04 | 281 |
| 2022 Q1 | 270,383,631 | $10,536,275,796 | +$82,755,109 | $38.96 | 272 |
| 2021 Q4 | 268,200,640 | $10,687,984,091 | +$139,946,049 | $39.85 | 254 |
| 2021 Q3 | 265,367,304 | $9,590,727,932 | +$538,289,516 | $36.14 | 226 |
| 2021 Q2 | 250,410,928 | $10,263,954,175 | +$118,347,007 | $40.99 | 229 |
| 2021 Q1 | 246,400,511 | $10,747,503,399 | +$874,104,377 | $43.62 | 208 |
| 2020 Q4 | 226,132,987 | $11,317,812,164 | +$1,961,711,795 | $50.05 | 188 |
| 2020 Q3 | 155,310,287 | $6,522,638,173 | +$367,540,942 | $42.07 | 129 |
| 2020 Q2 | 146,093,806 | $7,034,558,503 | +$7,034,558,867 | $48.55 | 119 |
| 2020 Q1 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q4 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q3 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q2 | 15 | $1,000 | $66.67 | 1 | |
| 2019 Q1 | 15 | $1,000 | $66.67 | 1 |